Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study to Identify Whether Doxycycline in SARS-CoV-2 Infection Protects Against Progression to a Severe Form.

NCT05445479 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05445479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05445479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study to Identify Whether Doxycycline in SARS-CoV-2 Infection Protects Against Progression to a Severe Form.
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Withdrawn
Start date
January 1, 2022
Completion date
January 1, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19